Results 101 to 110 of about 105,288 (139)

Polar lipids modify Alzheimer's Disease pathology by reducing astrocyte pro-inflammatory signaling through platelet-activating factor receptor (PTAFR) modulation. [PDF]

Lipids Health Dis
Hans S, Stanton JE, Sauer AK, Shiels K, Saha SK, Lordan R, Tsoupras A, Zabetakis I, Grabrucker AM.   +8 more
europepmc   +1 more source

Investigation of the involvement of platelet-activating factor in the control of hypertension by aerobic training. A randomized controlled trial. [PDF]

Biol Sport
Prado JP, Castro AE, Carvalho J, Pereira D, Faccioli LH, Sorgi C, Novaes R, Silva S, Galdino G.   +8 more
europepmc   +1 more source

Host-specific platelet-activating factor acetylhydrolase selectively remodels diacylglycerophospholipids to control schistosome development

Ertl J, Prodjinotho U, Rao Z, Anisuzzaman, Schluckebier J, Hamway Y, Baar P, Haslbeck M, Grevelding C, Haeberlein S, Falcone F, Schulz S, Koeberle A, Prazeres da Costa C.   +13 more
europepmc   +1 more source

Platelet Activating Factor Receptor and Intercellular Adhesion Molecule-1 Expression Increases in the Small Airway Epithelium and Parenchyma of Patients with Idiopathic Pulmonary Fibrosis: Implications for Microbial Pathogenesis. [PDF]

J Clin Med
Shahzad AM, Lu W, Dey S, Bhattarai P, Gaikwad AV, Jaffar J, Westall G, Sutherland D, Singhera GK, Hackett TL, Eapen MS, Sohal SS.   +11 more
europepmc   +1 more source

[Relationship Between Neonatal Outcomes and Changes in Serum Platelet-Activating Factor, Fibulin-3, and Umbilical Artery Blood Flow During Late Pregnancy in Pregnant Women With Gestational Hypertension]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Sun Y, Zhang H, Sun L.
europepmc   +1 more source

Associations between healthy food groups and platelet-activating factor, lipoprotein-associated phospholipase A₂ and C-reactive protein: a cross-sectional study. [PDF]

Eur J Nutr
English CJ, Jones M, Lohning AE, Mayr HL, MacLaughlin H, Reidlinger DP.   +5 more
europepmc   +1 more source

Severe Type 2 Inflammation Leads to High Platelet-Activating-Factor-Associated Pathology in Chronic Rhinosinusitis with Nasal Polyps-A Hierarchical Cluster Analysis Using Bulk RNA Barcoding and Sequencing. [PDF]

Int J Mol Sci
Ishino T, Oda T, Kawasumi T, Takemoto K, Nishida M, Horibe Y, Chikuie N, Taruya T, Hamamoto T, Ueda T, Takeno S.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Platelet-activating factor antagonists

Clinical Reviews in Allergy, 1995
The great number of PAF antagonists reviewed in this article clearly shows the tremendous effort made in the last 20 yr to explore the complex biological background of the mechanism of action of PAF and the potential clinical benefit of its antagonists. It is obvious that now highly potent, long-acting, and perorally applicable PAF-receptor antagonists
M, Koltai, P G, Braquet
openaire   +4 more sources

Platelet-Activating Factor

2007
Platelet-activating factor (PAF) is a potent mediator that occurs at very low concentrations in cells and tissues. Accurate quantitation of PAF has always been difficult because of the physicochemical properties of PAF and its structural similarity to several much more abundant phospholipids.
John S, Owen, Michael J, Thomas, Robert L, Wykle   +2 more
openaire   +3 more sources